Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > ELLIPSES PHARMA LTD
Company Information for

ELLIPSES PHARMA LTD

10 STRATTON STREET, LONDON, W1J 8LG,
Company Registration Number
09542015
Private Limited Company
Active

Company Overview

About Ellipses Pharma Ltd
ELLIPSES PHARMA LTD was founded on 2015-04-14 and has its registered office in London. The organisation's status is listed as "Active". Ellipses Pharma Ltd is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as GROUP
  • Group companies must submit full accounts if any company is a PLC (Public Limited Company)
  • Financial services firms: authorised insurance company, a banking company, an e-money issuer, a MiFID investment firm or a UCITS management company must submit full accounts even if they qualify as small
  • The combined turnover of the group must be < £6.5M, balance sheet <£3.26M and employ less than 50 people to not submit full accounts
Key Data
Company Name
ELLIPSES PHARMA LTD
 
Legal Registered Office
10 STRATTON STREET
LONDON
W1J 8LG
 
Filing Information
Company Number 09542015
Company ID Number 09542015
Date formed 2015-04-14
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/03/2023
Account next due 31/12/2024
Latest return 14/04/2016
Return next due 12/05/2017
Type of accounts GROUP
VAT Number /Sales tax ID GB236849962  
Last Datalog update: 2024-04-06 18:38:38
Primary Source:Companies House
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of ELLIPSES PHARMA LTD

Current Directors
Officer Role Date Appointed
JONATHAN MAXMIN
 Company Secretary 2017-01-20
DAVID COOK
 Director 2017-01-20
CHRISTOPHER THOMAS EVANS
 Director 2015-04-14
RAJAN VIPIN JETHWA
 Director 2015-05-01
FAHAD SALAH KHATER
 Director 2017-10-11
GORDON MCVIE
 Director 2017-01-20
Previous Officers
Officer Role Date Appointed Date Resigned
SHAFIA ZAHOOR
 Director 2015-04-14 2017-01-20

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
CHRISTOPHER THOMAS EVANS THE CANCER AWARENESS TRUST Director 2017-10-23 CURRENT 2017-10-23 Active
CHRISTOPHER THOMAS EVANS PERCEPTIVE NO 2 LIMITED Director 2015-09-23 CURRENT 2015-09-23 Dissolved 2016-08-02
CHRISTOPHER THOMAS EVANS ARIX BIOSCIENCE HOLDINGS LIMITED Director 2015-09-23 CURRENT 2015-09-23 Active
CHRISTOPHER THOMAS EVANS ARIX BIOSCIENCE PLC Director 2015-09-15 CURRENT 2015-09-15 Liquidation
CHRISTOPHER THOMAS EVANS PERSPECTIVE BIOSCIENCE INVESTMENTS LIMITED Director 2015-09-11 CURRENT 2015-09-11 Dissolved 2016-01-26
CHRISTOPHER THOMAS EVANS RUTHERFORD HEALTH PLC Director 2015-06-08 CURRENT 2015-02-04 Liquidation
CHRISTOPHER THOMAS EVANS MAGSTIM (HOLDINGS) 2 LIMITED Director 2014-07-30 CURRENT 2014-07-30 Dissolved 2015-10-06
CHRISTOPHER THOMAS EVANS MAGSTIM (HOLDINGS) LIMITED Director 2014-07-23 CURRENT 2014-07-23 Dissolved 2015-10-06
CHRISTOPHER THOMAS EVANS SIMBEC-ORION GROUP LIMITED Director 2013-05-02 CURRENT 2013-04-02 Active
CHRISTOPHER THOMAS EVANS PZT LIMITED Director 2013-04-23 CURRENT 2013-04-23 Active - Proposal to Strike off
CHRISTOPHER THOMAS EVANS SULTAN SCIENTIFIC LIMITED Director 2011-03-11 CURRENT 2005-03-14 Liquidation
CHRISTOPHER THOMAS EVANS MERLIN ASSET MANAGEMENT LIMITED Director 2005-08-04 CURRENT 2002-03-05 Dissolved 2016-01-26
CHRISTOPHER THOMAS EVANS ANONTEC LIMITED Director 2002-11-27 CURRENT 2002-11-26 Active - Proposal to Strike off

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-03-2726/03/24 STATEMENT OF CAPITAL GBP 122251.016
2024-03-13CONFIRMATION STATEMENT MADE ON 07/03/24, WITH UPDATES
2024-01-0530/12/23 STATEMENT OF CAPITAL GBP 121751.016
2024-01-0430/12/23 STATEMENT OF CAPITAL GBP 120126.016
2023-07-28GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/23
2023-06-1512/06/23 STATEMENT OF CAPITAL GBP 119806.016
2023-06-0724/05/23 STATEMENT OF CAPITAL GBP 119306.02
2023-04-03Appointment of David Cook as company secretary on 2023-03-31
2023-03-31Termination of appointment of Jonathan Maxmin on 2023-03-31
2023-03-15CONFIRMATION STATEMENT MADE ON 07/03/23, WITH UPDATES
2023-03-1407/03/23 STATEMENT OF CAPITAL GBP 117091.73
2022-12-12SH0112/12/22 STATEMENT OF CAPITAL GBP 116591.73
2022-12-12AAGROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/22
2022-11-30SH0130/11/22 STATEMENT OF CAPITAL GBP 116306.015
2022-08-15SH0110/08/22 STATEMENT OF CAPITAL GBP 115787.285
2022-08-08Resolutions passed:<ul><li>Resolution passed removal of pre-emption</ul>
2022-08-08RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
2022-08-01SH0129/07/22 STATEMENT OF CAPITAL GBP 98644.428
2022-06-28SH0128/06/22 STATEMENT OF CAPITAL GBP 97215.856
2022-05-27CH01Director's details changed for David Cook on 2022-05-20
2022-03-14CS01CONFIRMATION STATEMENT MADE ON 07/03/22, WITH UPDATES
2021-07-23AASMALL COMPANY ACCOUNTS MADE UP TO 31/03/21
2021-04-16RP04SH01Second filing of capital allotment of shares GBP96,615.547
2021-04-14SH0130/03/21 STATEMENT OF CAPITAL GBP 97214.856
2021-03-18CS01CONFIRMATION STATEMENT MADE ON 07/03/21, WITH UPDATES
2021-01-28TM01APPOINTMENT TERMINATED, DIRECTOR GORDON MCVIE
2020-08-14AA31/03/20 ACCOUNTS TOTAL EXEMPTION FULL
2020-03-10CS01CONFIRMATION STATEMENT MADE ON 07/03/20, WITH UPDATES
2020-03-10CS01CONFIRMATION STATEMENT MADE ON 07/03/20, WITH UPDATES
2020-03-10SH0105/03/20 STATEMENT OF CAPITAL GBP 96615.547
2020-03-10SH0105/03/20 STATEMENT OF CAPITAL GBP 96615.547
2020-02-04AD01REGISTERED OFFICE CHANGED ON 04/02/20 FROM 10 Stratton Street 10 Stratton Street London W1J 8LG England
2020-02-04AD01REGISTERED OFFICE CHANGED ON 04/02/20 FROM 10 Stratton Street 10 Stratton Street London W1J 8LG England
2020-02-04CH03SECRETARY'S DETAILS CHNAGED FOR JONATHAN MAXMIN on 2020-02-03
2020-02-04CH03SECRETARY'S DETAILS CHNAGED FOR JONATHAN MAXMIN on 2020-02-03
2020-02-04CH01Director's details changed for Fahad Salah Khater on 2020-02-03
2020-02-04CH01Director's details changed for Fahad Salah Khater on 2020-02-03
2020-02-03AD01REGISTERED OFFICE CHANGED ON 03/02/20 FROM Berkeley Square House Berkeley Square London W1J 6BD
2019-11-12SH0105/11/19 STATEMENT OF CAPITAL GBP 88943.147
2019-07-26AA31/03/19 ACCOUNTS TOTAL EXEMPTION FULL
2019-05-08RES01ADOPT ARTICLES 08/05/19
2019-03-20CS01CONFIRMATION STATEMENT MADE ON 07/03/19, WITH UPDATES
2019-03-06AP01DIRECTOR APPOINTED DR MAHA TAYSIR BARAKAT
2019-02-23AP01DIRECTOR APPOINTED MR WALEED AL MOKARRAB AL MUHAIRI
2019-02-12PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL ALI AHMED ABD AL MOUHSEN ALFRAYHAT
2019-01-16PSC07CESSATION OF CHRISTOPHER THOMAS EVANS AS A PERSON OF SIGNIFICANT CONTROL
2019-01-11PSC07CESSATION OF CHRISTOPHER CHIPPERTON AS A PERSON OF SIGNIFICANT CONTROL
2019-01-08PSC07CESSATION OF ECTOPLASM LIMITED AS A PERSON OF SIGNIFICANT CONTROL
2019-01-08SH0119/12/18 STATEMENT OF CAPITAL GBP 87110.64
2019-01-03RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of adoption of Articles of Association
2018-06-11AA31/03/18 ACCOUNTS TOTAL EXEMPTION FULL
2018-03-12CS01CONFIRMATION STATEMENT MADE ON 07/03/18, WITH UPDATES
2018-01-31LATEST SOC31/01/18 STATEMENT OF CAPITAL;GBP 55333.33
2018-01-31SH0118/01/18 STATEMENT OF CAPITAL GBP 55333.33
2017-11-13AP01DIRECTOR APPOINTED FAHAD SALAH KHATER
2017-10-25AA31/03/17 ACCOUNTS TOTAL EXEMPTION FULL
2017-10-09RP04CS01Second filing of Confirmation Statement dated 14/04/2017
2017-10-09ANNOTATIONClarification
2017-05-02LATEST SOC02/05/17 STATEMENT OF CAPITAL;GBP 50000
2017-05-02CS01CONFIRMATION STATEMENT MADE ON 14/04/17, WITH UPDATES
2017-04-05RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of adoption of Articles of Association
2017-04-05RES01ADOPT ARTICLES 30/03/2017
2017-02-16AP01DIRECTOR APPOINTED DAVID COOK
2017-02-10RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2017-02-10RES13SUB DIV 20/01/2017
2017-02-10RES10Resolutions passed:
  • Resolution of allotment of securities
  • Resolution of removal of pre-emption rights
  • Sub div 20/01/2017
2017-02-09SH0120/01/17 STATEMENT OF CAPITAL GBP 50090
2017-02-09SH02Sub-division of shares on 2017-01-20
2017-01-26AD01REGISTERED OFFICE CHANGED ON 26/01/17 FROM C/O Excalibur Berkeley Square House Berkeley Square London W1J 6BD United Kingdom
2017-01-26TM01APPOINTMENT TERMINATED, DIRECTOR SHAFIA ZAHOOR
2017-01-26AP03SECRETARY APPOINTED JONATHAN MAXMIN
2017-01-26AP01DIRECTOR APPOINTED GORDON MCVIE
2017-01-20TM01APPOINTMENT TERMINATED, DIRECTOR SHAFIA ZAHOOR
2017-01-10AA31/03/16 TOTAL EXEMPTION SMALL
2017-01-06RP04AR01SECOND FILING OF AR01 WITH A MADE UP DATE OF 14/04/16
2017-01-06ANNOTATIONClarification
2016-04-21LATEST SOC21/04/16 STATEMENT OF CAPITAL;GBP 100
2016-04-21AR0114/04/16 FULL LIST
2016-04-21AR0114/04/16 FULL LIST
2015-08-18AA01CURRSHO FROM 30/04/2016 TO 31/03/2016
2015-05-01AP01DIRECTOR APPOINTED MR RAJAN VIPIN JETHWA
2015-04-14MODEL ARTICLESMODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES
2015-04-14NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION
Industry Information
SIC/NAIC Codes
74 - Other professional, scientific and technical activities
749 - Other professional, scientific and technical activities n.e.c.
74909 - Other professional, scientific and technical activities n.e.c.




Licences & Regulatory approval
We could not find any licences issued to ELLIPSES PHARMA LTD or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Share
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against ELLIPSES PHARMA LTD
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
ELLIPSES PHARMA LTD does not have any mortgage charges so there is no mortgagee data available

  Average Max

This shows the max and average number of mortgages for companies with the same SIC code of 74909 - Other professional, scientific and technical activities n.e.c.

Intangible Assets
Patents
We have not found any records of ELLIPSES PHARMA LTD registering or being granted any patents
Domain Names
We do not have the domain name information for ELLIPSES PHARMA LTD
Trademarks

Trademark applications by ELLIPSES PHARMA LTD

ELLIPSES PHARMA LTD is the Original Applicant for the trademark ELLIPSES PHARMA ™ (88490321) through the USPTO on the 2019-06-26
"PHARMA"
ELLIPSES PHARMA LTD is the Original Applicant for the trademark ELLIPSES PHARMA ™ (88490321) through the USPTO on the 2019-06-26
"PHARMA"
ELLIPSES PHARMA LTD is the Original Applicant for the trademark ELLIPSES PHARMA ™ (88490321) through the USPTO on the 2019-06-26
"PHARMA"
ELLIPSES PHARMA LTD is the Original Applicant for the trademark ELLIPSES PHARMA ™ (88490321) through the USPTO on the 2019-06-26
"PHARMA"
Income
Government Income
We have not found government income sources for ELLIPSES PHARMA LTD. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (74909 - Other professional, scientific and technical activities n.e.c.) as ELLIPSES PHARMA LTD are:

Outgoings
Business Rates/Property Tax
No properties were found where ELLIPSES PHARMA LTD is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by ELLIPSES PHARMA LTD
OriginDestinationDateImport CodeImported Goods classification description
2018-11-0029379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)
2018-11-0029379000Hormones, natural or reproduced by synthesis; derivatives and structural analogues thereof, used primarily as hormones (excl. polypeptide hormones, protein hormones, glycoprotein hormones, steroidal hormones, catecholamine hormones, prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, and amino-acid derivatives, and products of 3002 10)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded ELLIPSES PHARMA LTD any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded ELLIPSES PHARMA LTD any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.
    Other companies at postcode W1J 8LG